NEW YORK (GenomeWeb News) – Dionex, a maker of liquid chromatography analysis systems, said today that it plans to buy ESA Biosciences' life sciences assets from ESA's parent company, Magellan Biosciences, including ESA's HPLC systems and clinical assays, as well as lab services.

The asset purchase agreement will give Sunnyvale, Calif.-based Dionex three lines of HPLC detectors. These products include the Corona Universal Charged Aerosol Detectors, which Dionex will sell with its own HPLC equipment or directly on third party systems.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.